Don't give up on the FDA decission - it will come through eventually. It may depend on the label claim. The FDA may want a number of limitation on when In Tube can be used (e.g. age of subjects, only immunocompetent subjects, etc) rather and a broad label claim for all LTBI testing. This would severely reduce the size of the market so CST would be right to "discuss" this with the FDA. This could be a reason for the delays.
Don't give up on the FDA decission - it will come through...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
